Cite
HARVARD Citation
Frampton, G. et al. (n.d.). 464 Comprehensive genomic profiling of advanced cancers identifies MET exon 14 alterations that are sensitive to MET inhibitors. European journal of cancer. pp. S99-S100. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Frampton, G. et al. (n.d.). 464 Comprehensive genomic profiling of advanced cancers identifies MET exon 14 alterations that are sensitive to MET inhibitors. European journal of cancer. pp. S99-S100. [Online].